|
Market Closed -
Nasdaq
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 2.280 USD | +6.05% |
|
+8.06% | +14.57% |
Company Valuation: Autolus Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 378.4 | 328.8 | 1,120 | 625.4 | 529.6 | 572.2 | - | - |
| Change | - | -13.12% | 240.67% | -44.17% | -15.31% | 8.05% | - | - |
| Enterprise Value (EV) 1 | 68.11 | -53.95 | 879.8 | 89.99 | 300.3 | 515.2 | 641.8 | 606.1 |
| Change | - | -179.21% | 1,730.86% | -89.77% | 233.7% | 71.58% | 24.57% | -5.57% |
| P/E | -2.63x | -1.21x | -5.37x | -2.73x | -1.84x | -2.95x | -3.72x | -4.6x |
| PBR | 1.51x | 1.1x | 10x | 1.46x | 2.97x | 20.7x | -7.13x | - |
| PEG | - | 0.1x | 0.2x | 0.1x | -0.1x | 0.1x | 0.2x | 0.2x |
| Capitalization / Revenue | 162x | 51.7x | 660x | 61.8x | 7.03x | 3.82x | 2.96x | 2.02x |
| EV / Revenue | 29.2x | -8.48x | 518x | 8.89x | 3.98x | 3.44x | 3.32x | 2.14x |
| EV / EBITDA | -0.44x | 0.35x | -5.08x | -0.39x | -1.15x | -2.76x | -3.76x | -6.79x |
| EV / EBIT | -0.42x | 0.33x | -4.9x | -0.37x | -1.11x | -2.73x | -4.13x | -5.38x |
| EV / FCF | -0.54x | 0.44x | -5.62x | -0.39x | -0.99x | -4.37x | -6.02x | -9.35x |
| FCF Yield | -186% | 228% | -17.8% | -254% | -101% | -22.9% | -16.6% | -10.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.97 | -1.57 | -1.2 | -0.86 | -1.08 | -0.7717 | -0.6125 | -0.496 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.33 | 6.36 | 1.698 | 10.12 | 75.39 | 149.8 | 193.5 | 283.4 |
| EBITDA 1 | -154.2 | -154.3 | -173.1 | -233.7 | -260.7 | -186.6 | -170.7 | -89.27 |
| EBIT 1 | -162.7 | -161.7 | -179.7 | -241.4 | -270.5 | -189 | -155.2 | -112.6 |
| Net income 1 | -142.1 | -148.8 | -208.4 | -220.7 | -287.5 | -213 | -181.3 | -120.4 |
| Net Debt 1 | -310.3 | -382.8 | -240.3 | -535.4 | -229.3 | -57 | 69.6 | 33.86 |
| Reference price 2 | 5.190 | 1.900 | 6.440 | 2.350 | 1.990 | 2.280 | 2.280 | 2.280 |
| Nbr of stocks (in thousands) | 72,919 | 173,059 | 173,937 | 266,122 | 266,143 | 266,163 | - | - |
| Announcement Date | 3/10/22 | 3/7/23 | 3/14/24 | 3/20/25 | 3/27/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.79x | 3.44x | -2.76x | - | 572M | |
| 18.61x | 4.33x | 10.21x | 0.49% | 80.23B | |
| 37.7x | 12.88x | 24.51x | -.--% | 50.64B | |
| 21.26x | 4.7x | 13.43x | 0.69% | 46.87B | |
| -51.83x | 3.58x | 10.59x | 2.95% | 46.34B | |
| 37.28x | 3.44x | 13.12x | -.--% | 31B | |
| -7.38x | 10.27x | -6.63x | -.--% | 25.28B | |
| 52.93x | 3.38x | 26.22x | -.--% | 24.36B | |
| 69.87x | 6.7x | 44.75x | -.--% | 20.81B | |
| 23.08x | 4.97x | 12.94x | -.--% | 16.08B | |
| Average | 19.87x | 5.77x | 14.64x | 0.46% | 34.22B | |
| Weighted average by Cap. | 17.76x | 6.01x | 15.18x | 0.61% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AUTL Stock
- Valuation Autolus Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
